Breast Cancer
Studies by C. Dang and co-authors describe new findings in breast cancer
Published in Women's Health Weekly, December 25th, 2008
"We conducted a pilot study of dose-dense epirubicin/cyclophosphamide (EC) x 6 -> paclitaxel (P) x 6 with pegfilgrastim. A previous dose-dense trial of FEC (5-fluorouracil [5-FU]/EC) x 6 with filgrastim -> by weekly paclitaxel alternating with docetaxel x 18 was not feasible because of pneumonitis (with dose-dense FEC) and pericardial/pleural effusion (taxane phase)," researchers in the United States report.
"Dose-dense EC (without the 5-FU) is not associated with pneumonitis, and dose-dense paclitaxel (alone) is feasible. Primary objective was feasibility. Patients with resectable breast cancer were enrolled, regardless of surgery status, tumor size, or nodal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Albert Einstein College of Medicine
Einstein researchers discover protein that contributes to cancer spread - American Association for Cancer Research
Selenium may prevent high risk-bladder cancer - Catholic University
A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart - JAMA and Archives Journals
Neither vitamin C or E associated with reduced risk of prostate cancer, or other cancers - Journal of the National Cancer Institute
Nonhormonal treatment regimens improve survival in patients with metastatic breast cancer - McGill University Health Centre
Lack of vitamin D causes weight gain and stunts growth in girls - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
